(S (NP (JJ Chronic) (NN disease) (NN progression)) (VP (VBZ is) (VP (VBG emerging) (PP (IN as) (NP (NP (DT an) (JJ important) (NN area)) (PP (IN of) (NP (NN investment))))) (PP (IN for) (NP (NN healthcare) (NNS providers))))) (. .))
(S (SBAR (IN As) (S (NP (NP (DT the) (NN quantity) (CC and) (NN richness)) (PP (IN of) (NP (JJ available) (JJ clinical) (NNS data)))) (VP (VBP continue) (S (VP (TO to) (VP (VB increase) (PP (IN along) (PP (IN with) (NP (NP (NNS advances)) (PP (IN in) (NP (NN machine) (NN learning)))))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (JJ great) (NN potential) (S (VP (TO to) (VP (VB advance) (NP (PRP$ our) (NNS approaches)) (PP (IN to) (S (VP (VBG caring) (PP (IN for) (NP (NNS patients))))))))))) (. .))
(S (S (NP (NP (DT An) (JJ ideal) (NN approach)) (PP (IN to) (NP (DT this) (NN problem)))) (VP (MD should) (VP (VB generate) (S (NP (NP (JJ good) (NN performance)) (PP (IN on) (NP (NP (QP (ADVP (IN at) (RBS least)) (CD three)) (NNS axes)) (ADVP (RB namely))))) (, ,) (NP (DT a)) (-RRB- -RRB-) (VP (VB perform) (PP (IN across) (NP (JJ many) (JJ clinical) (NNS conditions))) (PP (IN without) (S (VP (VBG requiring) (S (NP (NP (JJ deep) (JJ clinical) (NN expertise)) (CC or) (NP (JJ extensive) (NNS data))) (NP (NP (NN scientist) (NN effort)) (, ,) (NP (LST (NN b) (-RRB- -RRB-)) (NP (NN generalization)) (PP (IN across) (NP (NNS populations)))) (, ,))))))))))) (CC and) (S (LST (LS c) (-RRB- -RRB-)) (VP (VB be) (ADJP (JJ explainable) (PRN (-LRB- -LRB-) (NP (NN model) (NN interpretability)) (-RRB- -RRB-))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (NP (NNP SAVEHR)) (, ,) (NP (DT a) (ADJP (NN self) (HYPH -) (NN attention) (VBN based)) (NN architecture))) (PP (IN on) (NP (NP (JJ heterogeneous) (JJ structured) (NN EHR) (NNS data)) (SBAR (WHNP (WDT that)) (S (VP (VBZ achieves) (NP (NP (NML (NML ($ $)) (PP (SYM >) (NP ($ $) (CD 0.51)))) (NN AUC) (HYPH -) (NN PR)) (CC and) (NP (NML (NML ($ $)) (PP (SYM >) (NP ($ $) (CD 0.87)))) (NN AUC) (HYPH -) (NN ROC)) (NP (NNS gains))) (PP (IN on) (S (VP (VBG predicting) (NP (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (CD four) (JJ clinical) (NNS conditions) (PRN (-LRB- -LRB-) (NP (NP (NN CHF)) (, ,) (NP (NN Kidney) (NN Failure)) (, ,) (NP (NN Diabetes) (CC and) (NN COPD))) (-RRB- -RRB-))) (NP (NP (CD 15) (HYPH -) (NNS months)) (PP (IN in) (NP (NN advance))))))) (, ,) (CC and) (NP (NP (NNS transfers)) (PP (IN with) (NP (JJ high) (NN performance))))) (PP (IN onto) (NP (DT a) (JJ new) (NN population)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNP SAVEHR) (NN model)) (VP (VBZ performs) (ADJP (JJ superior) (S (VP (TO to)))) (SBAR (S (NP (NP (CD ten) (NNS baselines)) (PP (IN on) (NP (DT all) (CD three) (NNS axes)))) (VP (VBD stated) (ADVP (RB formerly))))))))) (. .))
